Trials / Conditions / Leber's Hereditary Optic Neuropathy (LHON)

Leber's Hereditary Optic Neuropathy (LHON)

7 registered clinical trials studyying Leber's Hereditary Optic Neuropathy (LHON) — 2 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	Pilot Study of the Efficacy of Nicotinamide (Vitamin B3) in Leber's Hereditary Optic Neuropathy NCT07258667	University Hospital, Angers	Phase 1
Completed	Evaluation of Impact of Disease and Visual Disability on Quality of Life and Loss of Independence of Patients NCT05555784	Argo Sante	—
Recruiting	Gene Therapy Clinical Trial for the Treatment Of Leber's HereDitary Optic Neuropathy NCT04912843	Wuhan Neurophth Biotechnology Limited Company	Phase 2 / Phase 3
Completed	Post Authorisation Safety Study With Raxone in LHON Patients NCT02771379	Santhera Pharmaceuticals	—
Completed	Historical Case Record Survey of Visual Acuity Data From Patients With Leber's Hereditary Optic Neuropathy (LH NCT02796274	Santhera Pharmaceuticals	—
Completed	Study to Assess the Efficacy and Safety of Raxone in LHON Patients NCT02774005	Santhera Pharmaceuticals	Phase 4
Terminated	Near-infrared Light-emitting Diode (NIR-LED) Therapy for Leber's Hereditary Optic Neuropathy (LHON) NCT01389817	Medical College of Wisconsin	Phase 1 / Phase 2